设为首页 |  加入收藏
首页期刊介绍编委会投稿须知通知公告刊登文章继续教育园地协办单位联系我们广告合作
公告栏:
ICU 抗菌药物耐药与临床药学监护
作者:  吴海燕   
单位:中山大学附属第一医院药学部,广东广州510080
关键词:抗菌药物 临床药学 耐药 
中图分类号:R97
文献标志码:A
出版年,卷(期):页码:2013,23(1):40-42,
收稿日期:2012 -12 -06
摘要:
临床药师可以积极参与到重症监护室(Intensive care unit, ICU)抗菌药物临床药学监护中,尤其针对抗菌药物的耐药。临床药师可通过专业优势在药代动力学、药效动力学参数规范抗菌药物的使用并提供个体化给药方案。也可以通过监督抗菌药物轮换使用的方式减少耐药率的发生。临床药师可以与感染控制科一同监测ICU 抗菌药物耐药率。并监督预防感染疫苗的使用。定期收集抗菌药物使用相关指标可以使临床药师更容易掌握耐药率情况,并通过多种渠道与临床医务人员及时沟通,有效控制ICU 患者抗菌药物耐药情况。
Clinical pharmacist can play an important role to administer antibiotic use in intensive care unit, especially in the antibiotic drug resistance. Clinical pharmacist can provide personalized dosage regimen through pharmacokinetics and pharmacodynamics parameter. Clinical pharmacist can also decrease antibiotic drug resistance through monitoring the rotation of the drug. Clinical pharmacist can monitor antibiotic drug resistance rate cooperate with infection control department, and clinical pharmacist can monitor the vaccines to prevent infection. Regular collection of antibiotics using index can easily control drug resistance rate, and on time connection to clinical staffs can effectively control antibiotic drug
resistance in intensive care unit.
基金项目:
广东省医院药学研究基金(编号:2009B020)
作者简介:
元 刚,临床药师,Tel:13570188011,E-mail:wongangzsu@163. com
通讯作者:
参考文献:
[1] Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals[J]. Clin Infect Dis, 1997,25(3):584 -599.
[2] Javis WR. Preventing the emergence of multidrug - resistant microorganisms through antimicrobial use controls: The complexity of the problem[J]. Infect Control Hosp Epidemiol, 1996, 17(8):490 -495.
[3] Forrest A, Nix DE, Ballow CH, et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients[J]. Antimicrob Agents Chemother, 1993, 37(5):1073 -1081.
[4] Schentag JJ. Antimicrobial action and pharmacokinetics/ pharmacodynamics. The use of AUIC to improve efficacy and avoid resistance[J]. J Chemother, 1999, 11(6):426-439.
[5] Hyatt JM, Schentag JJ. Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance[J]. Infect Control Hosp Epidemiol, 2000, 21(1Suppl):S18 -21.
[6] Blaser J, Stone BB, Groner MC, et al. Comparative study with enoxacin and netilimicin in a pharmacodynamic model to determine importance of ratio and antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance[J]. Antimicrob Agents Chemother, 1987, 31(7):1054 -1060.
[7] Thomas JK, Forrest A, Bhavnani SM, et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy[J].Antimicrob Agents Chemither, 1998, 42(3):521 -527.
[8] Gerding DN, Larson TA, Hughes RA, et al. Aminoglycoside resistance and aminoglycoside usage: Ten years of experience in one hospital[J]. Antimicrob Agents Chemother, 1991, 35(7):1284 -1290.
[9] Progress toward eliminating Haemophilus influenza type b disease among infants and children - United States,1987 -1997[J]. MMWR Morb Mortal Wkly Rep, 1998, 47(46):993 -998.
[10] Caputo GM, Appelbaum PC, Liu HH. Infections due to penicillin - resistant pneumococci. Clinical, epidemiologic, and microbiologic features [ J]. Arch Intern Med,1993, 153(11):1301 -1310.
[11] Jacobs MR. Treatment and diagnosis of infections caused by drug - resistant Streptococcus pneumonia[J]. Clin Infect Dis, 1992, 15(1):119 -127.
[12] Black S, Schinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northen California Kaiser Permanente Vaccine Study Center Group[J]. Pediatr Infect Dis J,2000, 19(3):187 -195.
[13] Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin - resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay[J]. J Clin Microbiol, 1999,37(8):2663 -2666.
[14] Chambers HF. Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications [J]. Clin Microbiol Rev, 1997, 10(4):781 -791.
[15] Patel R, Uhl JR, Kohner P, et al. Multiplex PCR detection of vanA, vanB, vanC - 1, and vanC - 2/3 genes in enterococci[J]. J Clin Microbiol, 1997, 35(3):703 -707.
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
 
友情链接  
广东今日药学杂志社有限公司   地址:广州市东风东路753号东塔7楼702
电话:020-37886325       邮箱:jinriyaoxue@163.com
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
粤ICP备20054928号

粤公网安备 44010402002138号

您是第 187155 位访问者